Anti-sCTLA-4 antibody 4017

  • Description

  • Application Data

Description

High affinity polyclonal antibody specifically targeting the soluble isoform of CTLA-4 (sCTLA-4)

See full description

Application Data

Catalogue number crb2005177
Antibody Anti-sCTLA-4 antibody 4017
Antigen Peptide KLH conjugated synthetic peptide crb1200374e
Protein ID UniProtKB - P16410
Aliases Cytotoxic T-lymphocyte protein 4, CD152 (cluster of differentiation 152)
Cross-Reactivity Human, mouse
Host Species Rabbit
Antibody Type Polyclonal
Concentration 0.85mg/ml
Validation WB/ELISA
Target sCTLA-4
Disease Area Immune homeostasis
Specificity Soluble CTLA-4
Citations

Esposito, L., Hunter, K., Clark, J., Rainbow, D., Stevens, H., Denesha, J., Duley, S., Dawson, S., Coleman, G., Nutland, S., Bell, G., Moran, C., Pekalski, M., Todd, J. and Wicker, L. (2014). Investigation of Soluble and Transmembrane CTLA-4 Isoforms in Serum and Microvesicles. J Immunol, 193(2), 889-900. PMID: 24928993

 

Sekiya, T. and Takaki, S. (2019). RGMB enhances the suppressive activity of the monomeric secreted form of CTLA-4. Sci Rep, 9(1). PMID: 31061392

References

Esposito, L., Hunter, K., Clark, J., Rainbow, D., Stevens, H., Denesha, J., Duley, S., Dawson, S., Coleman, G., Nutland, S., Bell, G., Moran, C., Pekalski, M., Todd, J. and Wicker, L. (2014). Investigation of Soluble and Transmembrane CTLA-4 Isoforms in Serum and Microvesicles. J Immunol, 193(2), 889-900. PMID: 24928993

 

Sekiya, T. and Takaki, S. (2019). RGMB enhances the suppressive activity of the monomeric secreted form of CTLA-4. Sci Rep, 9(1). PMID: 31061392

Material Safety Data Sheet (MSDS)

Cytotoxic T-lymphocyte-associated protein 4 (CTLA4) in an immunoglobulin superfamily receptor important for downregulating immune responses. CTLA4 is expressed in T-cells where it transmits an inhibitory signal to the cells.

The secreted soluble form of CTLA-4 (sCTLA-4) lacks the transmembrane domain as well as the membrane proximal cysteine residue required for covalent homodimerization and therefore sCTLA-4 is only present in monomeric form.

In human and mouse sCTLA-4 mRNA expression is mainly detected in resting T-cells, at levels similar to transmembrane CTLA-4 (Tm-CTLA-4) mRNA, however following T-cell activation, Tm-CTLA-4 is upregulated and becomes the predominant transcript. Mutations in CTLA4 are associated with multiple autoimmune diseases, including type 1 diabetes (T1D), Graves’ disease (GD), rheumatoid arthritis and celiac disease, an increase of sCTLA-4 is also seen in autoimmune diseases.

Anti-sCTLA-4 antibody 4017

Cat No.Pack SizePriceQty.
20ug£110.00
100ug£220.00
Bulk Quote

You may also like…